Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Eastern Virginia Bankshares, Inc. (EVBS) Going to Burn These Hedge Funds?

Page 1 of 2

Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth depends on it. Regardless of the various methods used by elite investors like David Tepper and Dan Loeb, the resources they expend are second-to-none. This is especially valuable when it comes to small-cap stocks, which is where they generate their strongest outperformance, as their resources give them a huge edge when it comes to studying these stocks compared to the average investor, which is why we intently follow their activity in the small-cap space.

Eastern Virginia Bankshares, Inc. (NASDAQ:EVBS) shareholders have witnessed an increase in hedge fund interest of late. It syncs perfectly with the stock trading sentiment, as the shares of the company jumped 6.97% during the third quarter. For a better understanding of the hedge fund behavior, we will find out more about the hedge funds holding positions in Eastern Virginia Bankshares, Inc. (NASDAQ:EVBS) at the end of the previous quarter.

The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Conatus Pharmaceuticals Inc (NASDAQ:CNAT), Alliqua Biomedical Inc (NASDAQ:ALQA), and YuMe Inc (NYSE:YUME) to gather more data points.

Follow Eastern Virginia Bankshares Inc (NASDAQ:EVBS)
Trade (NASDAQ:EVBS) Now!

In the eyes of most investors, hedge funds are assumed to be slow, outdated financial vehicles of yesteryear. While there are over 8000 funds trading today, we hone in on the leaders of this club, approximately 700 funds. These money managers have their hands on the majority of all hedge funds’ total asset base, and by monitoring their highest performing stock picks, Insider Monkey has determined numerous investment strategies that have historically outpaced the market. Insider Monkey’s small-cap hedge fund strategy beat the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Now, we’re going to take a look at the new action surrounding Eastern Virginia Bankshares, Inc. (NASDAQ:EVBS).

How are hedge funds trading Eastern Virginia Bankshares, Inc. (NASDAQ:EVBS)?

At the end of September, a total of 5 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 25% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were upping their holdings substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Emanuel J. Friedman’s EJF Capital has the most valuable position in Eastern Virginia Bankshares, Inc. (NASDAQ:EVBS), worth close to $4.5 million, amounting to 0.2% of its total 13F portfolio. The second largest stake is held by Basswood Capital, led by Matthew Lindenbaum, holding a $3.4 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Remaining hedge funds and institutional investors that hold long positions encompass Jeffrey Bronchick’s Cove Street Capital, Paul J. Isaac’s Arbiter Partners Capital Management. and Israel Englander’s Millennium Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!